CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndromes; Graft Vs Host Disease; Graft-versus-host-disease Interventions: Drug: Busulfan; Drug: Melphalan; Drug: Fludarabine; Device: CliniMACS CD34+ enriched, T-cell depleted peripheral blood stem cell (PBSC) Sponsor: Baptist Health South Florida Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials